Aldosterone receptor antagonists: focus on eplerenone

Area of Science:

• Cardiovascular Medicine
• Pharmacology

Background:

• Despite existing hypertension guidelines, blood pressure control remains suboptimal in the general population.
• Hypertension pathophysiology involves alterations in cardiac output and peripheral resistance, often linked to the renin-angiotensin-aldosterone system.
• Current treatments like ACE inhibitors and ARBs do not fully block aldosterone production.

Purpose of the Study:

• To review the renin-angiotensin-aldosterone system.
• To emphasize the role of aldosterone antagonism in hypertension management.
• To focus on the therapeutic application of eplerenone.

Main Methods:

• Literature review of the renin-angiotensin-aldosterone system.
• Analysis of aldosterone's role in hypertension.
• Summary of eplerenone's mechanism and clinical use.

Main Results:

• Aldosterone plays a significant role in hypertension, even with current therapies.
• Selective aldosterone receptor antagonists like eplerenone provide a targeted approach.
• Eplerenone is approved for hypertension treatment, alone or with other agents.

Conclusions:

• Aldosterone antagonism represents a valuable therapeutic avenue for hypertension.
• Eplerenone offers a new option for enhancing blood pressure control.
• Further re-evaluation of treatment strategies is crucial for effective hypertension management.